Wikipedia
Abiomed (NASDAQ: ABMD) is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 800 employees worldwide. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President. Minogue is a military veteran who served for four years on active duty in the U.S. Army and for eight years in the Army’s Individual Ready Reserve. Minogue served in Operation Desert Storm and earned multiple distinctions, including the Bronze Star. He is a 1989 graduate of the United States Military Academy at West Point.
Minogue helped found the Medical Technology Veterans Program (MVP), a career training and mentorship initiative designed to help veterans entering the civilian workforce transition into jobs in the medical device and life sciences industries.(*) He currently serves as chairman of the program.
For Fiscal Year 2016, Abiomed reported $329.5 million in revenue, $65.1 million in operating income, $38.1 million in net income, $423 million in total assets, and $369 million in equity.